Selected Publications
Christopher Perrone: Laying the foundation for the future: Considerations when building an MS registry 7th Tykeson Fellows Conference on Multiple Sclerosis, Atlanta, GA : 2019.
Susan Matesanz, Chelsea Kotch, Christopher Perrone, Angela J Waanders, Brook Hill, Sona Narula: Expanding the MOG phenotype: Brainstem encephalitis with punctate and curvilinear enhancement Neurology: Neuroimmunology & Neuroinflammation 6 (6): 2019.
AlexanderJ Gill, Michael A Perez, Christopher M Perrone, Charles J Bae, Amy A Pruitt, Eric Lancaster: A case series of PD-1 inhibitor-associated paraneoplastic neurologic syndromes Journal of Neuroimmunology 334 : 2019.
Christopher M. Perrone, Robert P. Lisak, Ethan I. Meltzer, Peter Sguigna, Etsegenet Tizazu, Dina Jacobs, Esther Melamed, Ashlea Lucas, Leorah Freeman, View ORCID ProfileGabriel Pardo, Andrew Goodman, Edward J. Fox, Kathleen Costello, Matthew S. Parsons, Scott S. Zamvil, Elliot M. Frohman, Teresa C. Frohman: Cataclysmically disseminating neurologic presentation in an immunosuppressed lupus patient: From the National Multiple Sclerosis Society Case Conference Proceedings Neurology: Neuroimmunology & Neuroinflammation 6 (4): 2019.
Perrone C, Datta R, Farrell C, Rao A, Markowitz C, Berger JR.: “Oligoclonal band number as a predictor of multiple
sclerosis disease course.” American Academy of Neurology Annual Meeting, Philadelphia, PA. : 2019.
Perrone C, Jacobs D.: “Oculomeningoencephalomyeloradiculitis: A case of fulminant varicella zoster infection in the
setting of systemic lupus erythematosus.” American Academy of Neurology Annual Meeting, Philadelphia, PA. : 2019.
Perrone C, Jacobs D.: “A case to screen for teriflunomide-associated neuropathy.” Consortium of Multiple Sclerosis
Centers, Seattle, WA. : 2019.
Gill AJ, Perez MA, Perrone C, Bae CJ, Pruitt AA, Lancaster E.: “Pembrolizumab-associated paraneoplastic disorders: A case series.”
American Academy of Neurology Annual Meeting, Philadelphia, PA
: 2019.
Perrone C, Markowitz C.: Case Study: Worsening symptoms while receiving interferon therapy for multiple sclerosis. Retrieved from https://www.neurologyadvisor.com. : 2019.
Perrone C, Berger JR, Markowitz C.: “Oligoclonal Band Number Correlates with Relapses and Progression in
Multiple Sclerosis.” Consortium of Multiple Sclerosis Centers, Nashville, TN, May 31.
: 2018.
Academic Contact Information
3400 Spruce Street, 3 W. Gates Building
Philadelphia,
PA
19104
Phone: 215-662-3606
Patient appointments: 800-789-7366